Barrow, Hanley, Mewhinney & Strauss’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.41K Hold
106
﹤0.01% 322
2025
Q4
$2.82K Hold
106
﹤0.01% 299
2025
Q3
$3.22K Buy
+106
New +$3.21K ﹤0.01% 296
2021
Q3
Sell
-913,226
Closed -$72M 323
2021
Q2
$72M Sell
913,226
-66,516
-7% -$5.09M 0.23% 90
2021
Q1
$73.9M Sell
979,742
-94,048
-9% -$6.9M 0.24% 94
2020
Q4
$70.7M Sell
1,073,790
-78,802
-7% -$4.61M 0.24% 93
2020
Q3
$62.2M Sell
1,152,592
-117,057
-9% -$6.43M 0.24% 87
2020
Q2
$61M Sell
1,269,649
-27,799
-2% -$1.23M 0.24% 89
2020
Q1
$44.2M Buy
1,297,448
+276,941
+27% +$15.2M 0.2% 87
2019
Q4
$63.9M Buy
1,020,507
+6,172
+0.6% +$349K 0.2% 93
2019
Q3
$50.7M Sell
1,014,335
-99,046
-9% -$4.68M 0.1% 115
2019
Q2
$53.7M Sell
1,113,381
-94,209
-8% -$4.54M 0.1% 120
2019
Q1
$61.7M Sell
1,207,590
-2,130
-0.2% -$93.4K 0.11% 113
2018
Q4
$43.5M Sell
1,209,720
-15,343
-1% -$716K 0.09% 130
2018
Q3
$76M Buy
1,225,063
+334,523
+38% +$19.1M 0.12% 113
2018
Q2
$47M Buy
890,540
+12,824
+1% +$693K 0.08% 143
2018
Q1
$48.2M Sell
877,716
-3,357
-0.4% -$207K 0.08% 139
2017
Q4
$60.1M Sell
881,073
-34,602
-4% -$2.33M 0.09% 132
2017
Q3
$65.6M Sell
915,675
-33,639
-4% -$2.34M 0.1% 126
2017
Q2
$64.3M Sell
949,314
-96,291
-9% -$6.57M 0.1% 125
2017
Q1
$70.7M Sell
1,045,605
-53,223
-5% -$3.55M 0.11% 124
2016
Q4
$68M Buy
+1,098,828
New +$64.9M 0.1% 127

Other funds holding ENOV

Barrow, Hanley, Mewhinney & Strauss's ENOV Position: Q1 2026 in Review

Barrow, Hanley, Mewhinney & Strauss held its Enovis (ENOV) position steady in Q1 2026 at 106 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #322.

Barrow, Hanley, Mewhinney & Strauss first reported a position in ENOV in Q4 2016 and has held it in 22 quarters since. The position peaked at $76M in Q3 2018. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 106 shares of Enovis worth $2.41K as of Q1 2026.
  • Barrow, Hanley, Mewhinney & Strauss left its Enovis share count unchanged in Q1 2026.
  • Enovis made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #322 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Enovis in Q4 2016 and has held it in 22 quarters since.
  • Barrow, Hanley, Mewhinney & Strauss's Enovis position peaked at $76M in Q3 2018.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.